Navigation Links
DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
Date:2/19/2013

Denver, CO (PRWEB) February 19, 2013

The medication resource center DrugRisk.com is alerting patients taking the blood thinner Pradaxa for atrial fibrillation that new information for the drug has been added to the site. Amid a new study warning of Pradaxa bleeding risks, reports show the number of patients filing legal claims for injury has increased.

“DrugRisk seeks to improve the safety of patients using popular drugs and medical devices by providing the latest warnings, recalls, studies and litigation news. With a drug like Pradaxa, this information can change monthly,“ explains DrugRisk representative Ryan Mayer.

The resource center contains information that shows experts still disagree about the safety of Pradaxa. The FDA recently issued an update that the drug carries the same risks as warfarin.* However, the American College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.**

Now, DrugRisk has added new information from the Institute for Safe Medication Practices, which ranks anticoagulants like Pradaxa among the most dangerous of outpatient drugs. Also, in reviewing reports of bleeding submitted to the FDA, the Institute found that bleeding caused by Pradaxa is nearly 5 times as likely to result in death than with warfarin.***

In legal news, the resource center has learned that, due to the number of patients filing Pradaxa lawsuits for bleeding side effects, the cases are being sent to a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

In the latest update from the Judicial Panel on Multi-District Litigation, court officials indicated the number of Pradaxa lawsuits filed had grown by nearly 17% in recent months and now approaches 200.****

Anyone affected by Pradaxa internal bleeding is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/Drugs/DrugSafety/ucm326580.htm
** http://content.onlinejacc.org/article.aspx?articleid=1206384
***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-January-2013.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-internal-bleeding/side-effects/prweb10442853.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
2. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
3. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
4. DrugRisk Announces New Pradaxa Health Warning From Australia
5. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
6. DrugRisk Announces Updated Information on Mirena Lawsuits
7. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
8. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
9. Pradaxa Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
10. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
11. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... 2016 , ... Amada Senior Care, premier provider of non-medical in-home care and ... San Antonio West location. Prior to entering the senior care industry, Amada franchise partner ... Amada San Antonio West will take place on Friday, April 29th. , ...
(Date:4/28/2016)... ... April 28, 2016 , ... Point Source ... microphones and headsets announced today that the US Patent Office has approved its ... a structure. This innovative design creates a lightweight and modular audio headset that ...
(Date:4/28/2016)... Tamarac, FL (PRWEB) , ... April 28, 2016 , ... ... body recovery supplement GlycoLoad at this week’s 2016 Europa Games Get Fit and ... health conscious consumers alike, the Europa Orlando Expo coming up April 29-30, was selected ...
(Date:4/28/2016)... Washington, D.C. (PRWEB) , ... April 28, 2016 , ... ... Control and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition ... by the medical community effective October 1, 2016. , Sarcopenia is defined as a ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... health insurance co-operative bankruptcy to receive their prescription medications through America’s fastest-growing ... FDA-approved prescription medications from over 180 American pharmaceutical companies for $35 per ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... , April 27, 2016  Bayer Animal ... a senior from the University of Florida College ... the Bayer Excellence in Communication Award (BECA). Brittany ... which were awarded a total of $70,000 in ... last four years, Bayer has provided a total ...
(Date:4/27/2016)... Global  urinalysis market  is ... 2022, according to a new report by Grand ... http://photos.prnewswire.com/prnh/20150105/723757 ) , Automation is ... accuracy delivered by the new generation urinalysis devices ... instruments and consumables. For instance, the automatic bench-top ...
(Date:4/26/2016)... Holdings, Inc. (NYSE: HRC ) invites you to ... st Annual Health Care Conference on Wednesday, May 4, ... to listen to the live discussion via the internet link ... http://edge.media-server.com/m/p/mr4uxgas . A recorded replay of the discussion will be ... accessible at the links above until August 1, 2016. ...
Breaking Medicine Technology: